The associations of body mass index, C-peptide and metabolic status in Chinese Type 2 diabetic patients

Diabetic Medicine

Volumn 21, Issue 4, 2004, Pages 349-353

  Chan, W B ^a   Tong, P C Y ^a   Chow, C C ^a   So, W Y ^a   Ng, M C Y ^a   Ma, R C W ^a   Osaki, R ^a   Cockram, C S ^a   Chan, J C N ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Body mass index; C peptide; Chinese; Diabetes

Indexed keywords

C PEPTIDE; HEMOGLOBIN A1C; INSULIN; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; BODY WEIGHT; CHINESE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES CONTROL; DIASTOLIC BLOOD PRESSURE; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREVALENCE; SYSTOLIC BLOOD PRESSURE; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; C-PEPTIDE; CHOLESTEROL; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HONG KONG; HUMANS; INSULIN; MALE; MIDDLE AGED; OBESITY; PATIENT EDUCATION;

EID: 1942423595     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01158.x     Document Type: Article

References (28)

1. Taylor SI, Accili D, Imai Y. Insulin resistance or insulin deficiency. Which is the primary cause of NIDDM? Diabetes 1994; 43: 735-40.
2. Wannamethee SG, Shaper AG, Durrington PN, Perry IJ. Hypertension, serum insulin, obesity and the metabolic syndrome. J Hum Hypertens 1998; 12: 735-41.
3. Chou P, Chen HH, Hsiao KJ. Community-based epidemiological study on diabetes in Pu-Li, Taiwan. Diabetes Care 1992; 15: 81-9.
4. Janus ED, Watt NM, Lam KS, Cockram CS, Siu ST, Liu LJ et al. The prevalence of diabetes, association with cardiovascular risk factors and implications of diagnostic criteria (ADA 1997 and WHO 1998) in a 1996 community-based population study in Hong Kong Chinese. Hong Kong Cardiovascular Risk Factor Steering Committee. American Diabetes Association. Diabet Med 2000; 17: 741-5.
5. Cockram CS. Diabetes mellitus: perspective from the Asia-Pacific region. Diabetes Res Clin Pract 2000; 50: S3-7.
6. Cockram CS, Woo J, Lau E, Chan JC, Chan AY, Lau J et al. The prevalence of diabetes mellitus and impaired glucose tolerance among Hong Kong Chinese adults of working age. Diabetes Res Clin Pract 1993; 21: 67-73.
7. Janus ED. Epidemiology of cardiovascular risk factors in Hong Kong. Clin Exp Pharmacol Physiol 1997; 24: 987-8.
8. Chan JC, Cheung CK, Swaminathan R, Nicholls MG, Cockram CS. Obesity, albuminuria and hypertension among Hong Kong Chinese with non-insulin-dependent diabetes mellitus (NIDDM). Postgrad Med J 1993; 69: 204-10.
9. Ko GT, Chan JC, Yeung VT, Chow CC, Li JK, Lau MS et al. Antibodies to glutamic acid decarboxylase in young Chinese diabetic patients. Ann Clin Biochem 1998; 35: 761-7.
10. Simmons D, Powell MJ. Metabolic and clinical characteristics of south Asians and Europeans in Coventry. Diabet Med 1993; 10: 751-8.
11. Cruickshank JK, Cooper J, Burnett M, MacDuff J, Drubra U. Ethnic differences in fasting plasma C-peptide and insulin in relation to glucose tolerance and blood pressure. Lancet 1991; 338: 842-7.
12. Prando R, Cheli V, Melga P, Giusti R, Ciuchi E, Odetti P. Is type 2 diabetes a different disease in obese and non-obese patients? Diabetes Care 1998; 21: 1680-5.
13. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995-2025: prevalence, numerical estimates, and projections. Diabetes Care 1998; 21: 1414-31.
14. World Health Organisation. Diabetes Mellitus. Report of a WHO Study group. Technical reports series 727. Geneva: World Health Organisation, 1985: 11.
15. World Health Organization. The Asia-Pacific Perspective: Redefining Obesity and its Treatment. World Health Organization, Western Pacific Region. Geneva: World Health Organization, 2000.
16. Emoto M, Nishizawa Y, Maekawa K, Hiura Y, Kanda H, Kawagishi T et al. Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas. Diabetes Care 1999; 22: 818-22.
17. Looker HC, Knowler WC, Hanson RL. Changes in BMI and weight before and after the development of type 2 diabetes. Diabetes Care 2001; 24: 1917-22.
18. Lee WR. The changing demography of diabetes mellitus in Singapore. Diabetes Res Clin Pract 2000; 50: S35-9.
19. Park SW, Ihm SH, Yoo HJ, Park JY, Lee KU. Differential effects of ambient blood glucose level and degree of obesity on basal serum C-peptide level and the C-peptide response to glucose and glucagon in non-insulin- dependent diabetes mellitus. Diabetes Res Clin Pract 1997; 37: 165-71.
20. Nielsen NV, Tronier B. C-peptide and insulin secretion in diabetes mellitus treated with oral hypoglycaemic agents or diet alone. A 3 years epidemiological cohort study on the Island of Falster, Denmark. Diabetes Res 1987; 4: 135-9.
21. Service FJ, Rizza RA, Zimmerman BR, Dyck PJ, O'Brien PC, Melton LJ 3rd. The classification of diabetes by clinical and C-peptide criteria. A prospective population-based study. Diabetes Care 1997; 20: 198-201.
22. Gero L, Koranyi L, Tamas G Jr. Residual B-cell function in insulin dependent (Type 1) and non insulin-dependent (Type 2) diabetics (relationship between 24-hour C-peptide excretion and the clinical features of diabetes). Diabetes Metab 1983; 9: 183-7.
23. Chan WB, Chan JC, Chow CC, Yeung VT, So WY, Li JK et al. Glycaemic control in type 2 diabetes: the impact of body weight, beta-cell function and patient education. QJM 2000; 93: 183-90.
24. Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-607.
25. Reaven GM. Resistance to insulin-stimulated glucose uptake and hyperinsulinemia: role in non-insulin-dependent diabetes, high blood pressure, dyslipidemia and coronary heart disease. Diabetes Metab 1991; 17: 78-86.
26. Ai M, Tanaka A, Ogita K, Sekine M, Numano F, Reaven GM. Relationship between hyperinsulinemia and remnant lipoprotein concentrations in patients with impaired glucose tolerance. J Clin Endocrinol Metab 2000; 85: 3557-60.
27. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS. 23). BMJ 1998; 316: 823-8.
28. Adler AI, Stratton IM, Neil HA, Yudkin JS, Matthews DR, Cull CA et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 2000; 321: 412-9.